Biodefense Market Report [2023-2030] | Top Key-Players are - Emergent Biosolutions, Hytest, GSK, Sanofi

PRESS RELEASE
Published April 10, 2023

Global "Biodefense Market” [2023-2030] research report offers in-depth analysis on Market size, share, drivers, restraints, and so on. Moreover, this report includes the approximate study of different segments in terms of overall growth, development, opportunity, business strategies, procedures etc. for the forecast period of 2030. The report contains the fundamentals produced and advancements by different application Share and The latest trend gaining momentum in the market that increases awareness about Biodefense market. The report supplies a comprehensive analysis of business aspects like global Biodefense market size, recent technological advances, and inventions. The research report consists of: introduction of the market, key players, opportunities, restraints, product and type classification, and overall market analysis.

The Biodefense Market report covers a wide range of topics, including keyword analysis, market size and share, competitive landscape, and industry trends. It also includes detailed profiles of key players in the market, along with their strategies, product offerings, and financial performance. | Ask for a Sample Report

The list of TOP KEY PLAYERS in the Biodefense Market Report are - Top Competitors Data

  • Emergent Biosolutions
  • Hytest
  • GSK
  • Sanofi
  • PharmAthene
  • Bavarian Nordic
  • SIGA Technologies
  • Arbutus Biopharma
  • DynPort Vaccine
  • Xoma Corporation
  • Ichor Medical Systems
  • Aeolus Pharmaceuticals
  • Achaogen
  • Elusys Therapeutics
  • Dynavax Technologies
  • Cleveland BioLabs
  • Soligenix
  • Alnylam Pharmaceuticals

“The information for each competitor includes, Company Profile, Main Business Information, SWOT Analysis, Sales, Revenue, Price and Gross Margin, Market Share, etc.”

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities are covered in the study.
  • A neutral perspective on the market performance.
  • Recent industry trends and developments.
  • Competitive landscape and strategies of key players.
  • Potential and niche segments and regions exhibiting promising growth are covered.
  • Historical, current, and projected market size, in terms of value.
  • In-depth analysis of the Biodefense Market.
  • Overview of the regional outlook of the Biodefense Market.

Get a sample PDF of the report at - https://www.researchreportsworld.com/enquiry/request-sample/16072285

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.

Market Analysis and Insights: Global Biodefense Market

The research report studies the Biodefense market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Biodefense market size is projected to reach USD 1627.2 million by 2030, from USD 1066.2 million in 2022, at a CAGR of 7.3% during 2023-2030.

Global Biodefense Scope and Segment

The global Biodefense market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biodefense market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2030.

Biodefense Market Size in 2023 - Report Overview

The analysis report for the Biodefense market provides a comprehensive assessment of the global market, including regional and country-level market sizes, segmentation, market growth, market share, competitive landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expansion, and technological innovations.

The report introduces the statistical scope of the Biodefense market shares, market division standards, and market research methods, and also includes an executive summary of different market segments by region, product type, application, and more, including the market size of each segment and future development potential. The report offers a high-level view of the current state of the Biodefense Market, its likely evolution in the short to mid-term, and the long term. Additionally, the report provides a detailed analysis of the market's competitive landscape and offers information on market share, capacity, output, price, latest development plan, merger, and acquisition of the main manufacturers in the market.

Enquire before purchasing this report - https://www.researchreportsworld.com/enquiry/pre-order-enquiry/16072285

On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into:

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
  • Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:

  • US Military Market
  • US Civilian Market
  • Non - US Market

Geographic Segmentation -

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

COVID-19 Impact on the Market -

The recent COVID-19 outbreak first began in Wuhan (China) in December 2019, and since then, it has spread around the globe at a fast pace. China, Italy, Iran, Spain, the Republic of Korea, France, Germany, and the US are among the worst-affected countries in terms of positive cases and reported deaths, as of March 2020. The COVID-19 outbreak has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. After more than two years of the pandemic, the global economy began to recover, entering 2022, the Russian Federation’s invasion of Ukraine and its global effects on commodity markets, supply chains, inflation, and financial conditions have steepened the slowdown in global growth. In particular, the war in Ukraine is leading to soaring prices and volatility in energy markets, with improvements in activity in energy exporters more than offset by headwinds to activity in most other economies. The invasion of Ukraine has also led to a significant increase in agricultural commodity prices, which is exacerbating food insecurity and extreme poverty in many emerging markets and developing economies.

To Know How Covid-19 Pandemic and Russia-Ukraine War Will Impact This Market- Get a Sample Copy of the Report

Reasons to Purchase this Report:

  • Analyzing the outlook of the market with the recent trends and SWOT analysis.
  • Market dynamics scenario, along with growth opportunities of the market in the years to come.
  • Market segmentation analysis includes qualitative and quantitative research incorporating the impact of economic and non-economic aspects.
  • Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past years.
  • Comprehensive company profiles covering product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players.

Purchase this report (Price 3350 USD for single user license) - https://www.researchreportsworld.com/purchase/16072285

Major Points from Table of Contents:

Table of Contents

1 Market Overview of Biodefense
1.1 Biodefense Market Overview
1.1.1 Biodefense Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biodefense Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Biodefense Market Size by Region (2015-2026)
1.4 Global Biodefense Historic Market Size by Region (2015-2020)
1.5 Global Biodefense Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Biodefense Market Size Growth (2015-2026)
1.6.1 North America Biodefense Market Size Growth (2015-2026)
1.6.2 Europe Biodefense Market Size Growth (2015-2026)
1.6.3 Asia-Pacific Biodefense Market Size Growth (2015-2026)
1.6.4 Latin America Biodefense Market Size Growth (2015-2026)
1.6.5 Middle East and Africa Biodefense Market Size Growth (2015-2026)

2 Biodefense Market Overview by Type
2.1 Global Biodefense Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Biodefense Historic Market Size by Type (2015-2020)
2.3 Global Biodefense Forecasted Market Size by Type (2021-2026)
2.4 Anthrax
2.5 Smallpox
2.6 Botulism
2.7 Radiation/Nuclear
2.8 Others

3 Biodefense Market Overview by Application
3.1 Global Biodefense Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Biodefense Historic Market Size by Application (2015-2020)
3.3 Global Biodefense Forecasted Market Size by Application (2021-2026)
3.4 US Military Market
3.5 US Civilian Market
3.6 Non - US Market

4 Global Biodefense Competition Analysis by Players
4.1 Global Biodefense Market Size (Million USD) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biodefense as of 2019)
4.3 Date of Key Manufacturers Enter into Biodefense Market
4.4 Global Top Players Biodefense Headquarters and Area Served
4.5 Key Players Biodefense Product Solution and Service
4.6 Competitive Status
4.6.1 Biodefense Market Concentration Rate
4.6.2 Mergers and Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Emergent Biosolutions
5.1.1 Emergent Biosolutions Profile
5.1.2 Emergent Biosolutions Main Business
5.1.3 Emergent Biosolutions Products, Services and Solutions
5.1.4 Emergent Biosolutions Revenue (USD Million) and (2015-2020)
5.1.5 Emergent Biosolutions Recent Developments
5.2 Hytest
5.2.1 Hytest Profile
5.2.2 Hytest Main Business and Company’s Total Revenue
5.2.3 Hytest Products, Services and Solutions
5.2.4 Hytest Revenue (USD Million) (2015-2020)
5.2.5 Hytest Recent Development and Reaction to Covid-19
5.3 GSK
5.5.1 GSK Profile
5.3.2 GSK Main Business
5.3.3 GSK Products, Services and Solutions
5.3.4 GSK Revenue (USD Million) and (2015-2020)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Products, Services and Solutions
5.4.4 Sanofi Revenue (USD Million) and (2015-2020)
5.4.5 Sanofi Recent Developments
5.5 PharmAthene
5.5.1 PharmAthene Profile
5.5.2 PharmAthene Main Business
5.5.3 PharmAthene Products, Services and Solutions
5.5.4 PharmAthene Revenue (USD Million) and (2015-2020)
5.5.5 PharmAthene Recent Developments
5.6 Bavarian Nordic
5.6.1 Bavarian Nordic Profile
5.6.2 Bavarian Nordic Main Business
5.6.3 Bavarian Nordic Products, Services and Solutions
5.6.4 Bavarian Nordic Revenue (USD Million) and (2015-2020)
5.6.5 Bavarian Nordic Recent Developments
5.7 SIGA Technologies
5.7.1 SIGA Technologies Profile
5.7.2 SIGA Technologies Main Business and Company’s Total Revenue
5.7.3 SIGA Technologies Products, Services and Solutions
5.7.4 SIGA Technologies Revenue (USD Million) (2015-2020)
5.7.5 SIGA Technologies Recent Development and Reaction to Covid-19
5.8 Arbutus Biopharma
5.8.1 Arbutus Biopharma Profile
5.8.2 Arbutus Biopharma Main Business
5.8.3 Arbutus Biopharma Products, Services and Solutions
5.8.4 Arbutus Biopharma Revenue (USD Million) and (2015-2020)
5.8.5 Arbutus Biopharma Recent Developments
5.9 DynPort Vaccine
5.9.1 DynPort Vaccine Profile
5.9.2 DynPort Vaccine Main Business
5.9.3 DynPort Vaccine Products, Services and Solutions
5.9.4 DynPort Vaccine Revenue (USD Million) and (2015-2020)
5.9.5 DynPort Vaccine Recent Developments
5.10 Xoma Corporation
5.10.1 Xoma Corporation Profile
5.10.2 Xoma Corporation Main Business
5.10.3 Xoma Corporation Products, Services and Solutions
5.10.4 Xoma Corporation Revenue (USD Million) and (2015-2020)
5.10.5 Xoma Corporation Recent Developments
5.11 Ichor Medical Systems
5.11.1 Ichor Medical Systems Profile
5.11.2 Ichor Medical Systems Main Business
5.11.3 Ichor Medical Systems Products, Services and Solutions
5.11.4 Ichor Medical Systems Revenue (USD Million) and (2015-2020)
5.11.5 Ichor Medical Systems Recent Developments
5.12 Aeolus Pharmaceuticals
5.12.1 Aeolus Pharmaceuticals Profile
5.12.2 Aeolus Pharmaceuticals Main Business
5.12.3 Aeolus Pharmaceuticals Products, Services and Solutions
5.12.4 Aeolus Pharmaceuticals Revenue (USD Million) and (2015-2020)
5.12.5 Aeolus Pharmaceuticals Recent Developments
5.13 Achaogen
5.13.1 Achaogen Profile
5.13.2 Achaogen Main Business
5.13.3 Achaogen Products, Services and Solutions
5.13.4 Achaogen Revenue (USD Million) and (2015-2020)
5.13.5 Achaogen Recent Developments
5.14 Elusys Therapeutics
5.14.1 Elusys Therapeutics Profile
5.14.2 Elusys Therapeutics Main Business
5.14.3 Elusys Therapeutics Products, Services and Solutions
5.14.4 Elusys Therapeutics Revenue (USD Million) and (2015-2020)
5.14.5 Elusys Therapeutics Recent Developments
5.15 Dynavax Technologies
5.15.1 Dynavax Technologies Profile
5.15.2 Dynavax Technologies Main Business
5.15.3 Dynavax Technologies Products, Services and Solutions
5.15.4 Dynavax Technologies Revenue (USD Million) and (2015-2020)
5.15.5 Dynavax Technologies Recent Developments
5.16 Cleveland BioLabs
5.16.1 Cleveland BioLabs Profile
5.16.2 Cleveland BioLabs Main Business and Company’s Total Revenue
5.16.3 Cleveland BioLabs Products, Services and Solutions
5.16.4 Cleveland BioLabs Revenue (USD Million) (2015-2020)
5.16.5 Cleveland BioLabs Recent Development and Reaction to Covid-19
5.17 Soligenix
5.17.1 Soligenix Profile
5.17.2 Soligenix Main Business
5.17.3 Soligenix Products, Services and Solutions
5.17.4 Soligenix Revenue (USD Million) and (2015-2020)
5.17.5 Soligenix Recent Developments
5.18 Alnylam Pharmaceuticals
5.18.1 Alnylam Pharmaceuticals Profile
5.18.2 Alnylam Pharmaceuticals Main Business
5.18.3 Alnylam Pharmaceuticals Products, Services and Solutions
5.18.4 Alnylam Pharmaceuticals Revenue (USD Million) and (2015-2020)
5.18.5 Alnylam Pharmaceuticals Recent Developments

6 North America
6.1 North America Biodefense Market Size by Country
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Biodefense Market Size by Country

With tables and figures helping analyses worldwide Global Biodefense Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

…Continued

Browse the complete table of contents at -

https://www.researchreportsworld.com/TOC/16072285

About Us:

Research Reports World - is a credible source for gaining market reports that will provide you with the lead your business needs. At Research Reports World, our objective is to provide a platform for many top-notch market research firms worldwide to publish their research reports, as well as help the decision-makers in finding the most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:

Research Reports World

Phone:

US - (+1) 424 253 0807

UK - (+44) 203 239 8187

Email: sales@researchreportsworld.com

Website: https://www.researchreportsworld.com

Our Other Reports:

Global Digital Learning Platforms Market [2023-2030] | Comprehensive Analysis on Industry Trends and Future Forecast

Global Logistics Real Estate Market [2023 to 2030] Predicted to Grow at a Remarkable Pace

Global Farm Animal Insurance Market [2023-2030] | Intelligence Insights

How the Metal Shredders Market Will Evolve by 2023-2030 | Expert Analysis

Vapor Products Market [2023-2030] | Comprehensive Report on Industry Trends and Forecast

Global Walk-Behind Lawn Mowers Market [2023-2030] | Size, Share, Growth Opportunities, Regional Analysis

Starch Syrup Market [2023-2030] | Discover Worldwide Opportunities in the Industry

Power Assist Wheelchairs Market [2023-2030] | Industry Analysis, Trends and Future Forecast

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Biodefense Market Report [2023-2030] | Top Key-Players are - Emergent Biosolutions, Hytest, GSK, Sanofi

TheExpressWire